x

RSS Newsfeeds

See all RSS Newsfeeds

Global Regions

United States ( XML Feed )

Jun 9, 2016 11:17 EST

INVEST IN BETA BIONICS – Building a bionic pancreas to improve the lives of people with type 1 diabetes

iCrowdNewswire - Jun 9, 2016

INVEST IN BETA BIONICS

Building a bionic pancreas to improve the lives of people with type 1 diabetes

At Beta Bionics, Inc., we have developed a bionic pancreas called the iLet™, a pocket-sized, wearable medical device that autonomously manages blood sugar levels in people with diabetes. Our iLet technology has demonstrated dramatic improvements in clinical outcomes. Through its ability to continuously adapt to the ever-changing insulin needs of people with diabetes, the iLet is the quintessential embodiment of personalized medicine – a sturdy and irrevocable bridge to the ever-elusive cure.

Square_cropped_large_cropped_damiano

Edward Damiano
CEO, BETA BIONICS
 
 
 

OUR AMBITION

We are driven to build a technology that will automatically manage our children’s diabetes, day and night, and keep them safe from the far-reaching harms, the immediate dangers, the emotional burden, and the fear that type 1 diabetes carries with it every day of their lives. That technology will provide a bridge that spans the divide between where we are today and the biological cure of tomorrow – a cure that has been ever present in our dreams, and ever elusive from our lives.

KEY FACTS

  • 6 outpatient human clinical trials already completed.
  • Backed by nearly 10 years of clinical data.

 

Contact Information:

Edward Damiano

View Related News >
support